Streetbeat News

Equity Actions

NRXP

NRx Pharmaceuticals plans to conduct an underwritten public offering of its common stock, with the size and terms yet to be disclosed. The proceeds are intended for working capital, general corporate purposes, and potentially to repay certain outstanding debts. The offering's success is subject to market conditions.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:03 pm

CVX

Chevron (NYSE:CVX) has seen a significant uptick in options trading activity, with a notable bias towards bullish sentiment. Benzinga's options scanner revealed 20 unusual trades, with 60% being bullish and 40% bearish, indicating expectations for CVX's stock price to reach between $120 and $180 in the next three months. The company, a major player in the energy sector, has a current stock price of $154.62, with market experts setting a consensus target price of $175. The recent options activity could suggest insider knowledge or speculation on future price movements.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:31 pm

AHG

Akso Health Group has filed for a mixed shelf offering with the SEC, allowing it to issue up to $400 million in securities. This strategic move could provide the company with flexible financing options for future growth, acquisitions, or debt management.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 7:51 pm

ACCD

Accolade (NASDAQ:ACCD) has received mixed analyst ratings over the past quarter, with 7 analysts offering opinions ranging from bullish to bearish. Recent updates show a shift towards more positive ratings, with an average 12-month price target of $15.29, reflecting a 15.83% increase from the previous target of $13.20. Analysts from firms like Leerink Partners, Needham, and Raymond James have adjusted their ratings and price targets, indicating a generally positive outlook on Accolade's performance despite its challenges in revenue growth, net margin, and ROE compared to industry peers.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:01 pm

SPG

Simon Property Group (NYSE:SPG) received mixed analyst ratings in the last quarter, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target was raised to $148.0, indicating an 8.29% increase from the previous target. Analysts from Morgan Stanley, Truist Securities, Goldman Sachs, and Piper Sandler adjusted their ratings and price targets, reflecting dynamic market conditions and Simon Property Group's performance. The company, a major real estate investment trust in the US, showed strong financial indicators including revenue growth, net margin, ROE, and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:01 pm

MAIN

Main Street Capital (NYSE:MAIN) has received mixed analyst ratings over the past quarter, with a shift towards a more indifferent stance in the last 30 days. The average 12-month price target for MAIN has been raised to $45.75, indicating a 5.59% increase from the previous target of $43.33. Analysts from Oppenheimer, Truist Securities, RBC Capital, and B. Riley Securities have updated their ratings and price targets, reflecting a positive outlook on MAIN's financial performance, including a notable revenue growth rate of 22.99%, a high net margin of 90.83%, and strong ROE and ROA figures.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:00 pm

BHP

GLNCY

VALE

The nickel industry is facing a prolonged period of oversupply, leading to production cutbacks by major miners like Nornickel, BHP Group, Glencore, and Vale in response to falling prices and high operating costs. These cutbacks are aimed at supporting market prices and managing costs amid weak demand from the stainless steel and EV sectors. Several companies have recorded significant impairment charges, and some are considering operational adjustments to navigate the challenging market conditions.

Portfolio Pulse from Matt Whittaker

February 26, 2024 | 6:32 pm

DSWL

Deswell Industries, Inc. (NASDAQ:DSWL) announced the unanimous election of Ms. Lau Wai Ming as Chairman of the Board, effective February 19, 2024. She was elected to the Board by shareholders at the 2023 Annual Meeting on February 6, 2024.

Portfolio Pulse from Charles Gross

February 26, 2024 | 6:02 pm

ACON

Aclarion, Inc. shares are trading lower following the announcement of a $3 million public offering. The move to raise capital through a public offering has led to a decrease in the stock price as investors react to the potential dilution of their shares.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 6:02 pm

PHR

Phreesia (NYSE:PHR) has received mixed reviews from 7 financial analysts over the past quarter, with recent ratings ranging from bullish to bearish. The average 12-month price target for PHR has been adjusted to $29.29, down from $37.25, indicating a 21.37% decrease. Analysts have adjusted their ratings and price targets in response to market dynamics and Phreesia's performance, with some maintaining their positive outlook while others have lowered their expectations. Phreesia's financials show a positive revenue trend with a 25.33% growth rate as of October 31, 2023, but its net margin and ROA lag behind industry averages, despite a strong ROE and prudent debt management.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 6:01 pm